Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company's segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases. Its Hematology products include ADVATE (Antihemophilic Factor (Recombinant)), ADYNOVATE/ADYNOVI (Antihemophilic Factor (Recombinant), PEGylated)), RIXUBIS (Coagulation Factor IX (Recombinant)), VONVENDI (von Willebrand factor (Recombinant)) and FEIBA (Anti-Inhibitor Coagulant Complex). Its Genetic Diseases products include CINRYZE (C1 esterase inhibitor (human)), FIRAZYR (icatibant), ELAPRASE (idursulfase), REPLAGAL (agalsidase alfa) and VPRIV (velaglucerase alfa).
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Pharmaceuticals
- Sub-Industry: N/A
- Symbol: LON:SHP
- CUSIP: N/A
- Web: www.shire.com/
Capitalization:- Market Cap: £34.67 billion
- Outstanding Shares: 906,400,000
Average Prices:- 50 Day Moving Avg: GBX 3,912.51
- 200 Day Moving Avg: GBX 4,376.95
- 52 Week Range: GBX 3,603.50 - GBX 5,377
P/E:- Trailing P/E Ratio: 51.34
- P/E Growth: 1.10
Sales & Book Value:- Annual Revenue: £14.58 billion
- Price / Sales: 2.38
- Book Value: GBX 34.49 per share
- Price / Book: 1.11
Dividend:
Profitability:- EBIDTA: £5.76 billion
- Net Margins: 6.33%
- Return on Equity: 3.18%
- Return on Assets: 1.43%
Misc:- Average Volume: 2.57 million shs.
Frequently Asked Questions for Shire PLC (LON:SHP)
What is Shire PLC's stock symbol?
Shire PLC trades on the London Stock Exchange (LON) under the ticker symbol "SHP."
How often does Shire PLC pay dividends? What is the dividend yield for Shire PLC?
Shire PLC announced a dividend on Thursday, August 3rd. Investors of record on Thursday, September 7th will be given a dividend of GBX 3.85 per share on Friday, October 20th. This represents a yield of 0.1%. The ex-dividend date of this dividend is Thursday, September 7th. The official announcement can be viewed at this link. View Shire PLC's Dividend History.
When will Shire PLC make its next earnings announcement?
Where is Shire PLC's stock going? Where will Shire PLC's stock price be in 2017?
17 equities research analysts have issued 1 year price targets for Shire PLC's stock. Their forecasts range from GBX 4,400 to GBX 7,500. On average, they anticipate Shire PLC's share price to reach GBX 5,889.63 in the next twelve months. View Analyst Ratings for Shire PLC.
Who are some of Shire PLC's key competitors?
Some companies that are related to Shire PLC include AstraZeneca plc (AZN), Shire PLC (SHPG), Teva Pharmaceutical Industries Limited (TEVA), Dr. Reddy's Laboratories Ltd (RDY), Catalent (CTLT), Patheon NV (PTHN), Valeant Pharmaceuticals International (VRX), Taro Pharmaceutical Industries (TARO), Akorn (AKRX), Opko Health (OPK), Hikma Pharmaceuticals Plc (HIK), BTG plc (BTG), Amicus Therapeutics (FOLD), Corcept Therapeutics Incorporated (CORT), Horizon Pharma PLC (HZNP), Theravance Biopharma (TBPH), Akcea Therapeutics (AKCA) and Cambrex Corporation (CBM).
Who are Shire PLC's key executives?
Shire PLC's management team includes the folowing people:
- Flemming Ornskov M.D., Chief Executive Officer, Executive Director
- Jeffrey Poulton, Chief Financial Officer, Executive Director
- Joanne Cordeiro, Chief Human Resource Officer
- William Mordan, General Counsel, Company Secretary
- Perry Sternberg, Head - U.S. Commercial
- Kim Stratton, Head - International Commercial
- Philip J. Vickers, Head - Research and Development
- Matthew Walker, Head - Technical Operations
- Susan Saltzbart Kilsby, Independent Non-Executive Chairman of the Board
- Olivier Bohuon, Non-Executive Director
How do I buy Shire PLC stock?
Shares of Shire PLC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Shire PLC's stock price today?
One share of Shire PLC stock can currently be purchased for approximately GBX 3,824.50.
MarketBeat Community Rating for Shire PLC (LON SHP)MarketBeat's community ratings are surveys of what our community members think about Shire PLC and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for Shire PLC (LON:SHP) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 3 Hold Ratings, 13 Buy Ratings, 1 Strong Buy Rating |
| Consensus Rating: | Buy (Score: 2.88) |
| Consensus Price Target: | GBX 5,889.63 |
Analysts' Ratings History for Shire PLC (LON:SHP)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 9/20/2017 | Shore Capital | Reiterated Rating | Buy | |  |
| 9/13/2017 | J P Morgan Chase & Co | Lower Price Target | Overweight | GBX 5,500 -> GBX 5,300 | |
| 9/5/2017 | Deutsche Bank AG | Lower Price Target | Buy | GBX 6,000 -> GBX 5,700 | |
| 8/22/2017 | Credit Suisse Group | Reiterated Rating | Outperform | GBX 5,350 | |
| 8/22/2017 | Jefferies Group LLC | Reiterated Rating | Buy | | |
| 8/22/2017 | Citigroup Inc. | Reiterated Rating | Buy | GBX 6,300 | |
| 8/11/2017 | Liberum Capital | Lower Price Target | Hold | GBX 4,900 -> GBX 4,400 | |
| 8/11/2017 | Barclays PLC | Downgrade | Equal weight | | |
| 8/9/2017 | Berenberg Bank | Reiterated Rating | Buy | GBX 6,000 | |
| 8/4/2017 | Beaufort Securities | Reiterated Rating | Long Term Buy | GBX 6,200 -> GBX 4,900 | |
| 7/12/2017 | Societe Generale | Reiterated Rating | Buy | GBX 7,500 | |
| 7/7/2017 | Royal Bank Of Canada | Reiterated Rating | Outperform | | |
| 7/6/2017 | HSBC Holdings plc | Upgrade | Hold | GBX 4,450 | |
| 6/28/2017 | Goldman Sachs Group, Inc. (The) | Lower Price Target | Conviction-Buy | GBX 6,800 -> GBX 6,400 | |
| 4/3/2017 | BNP Paribas | Reiterated Rating | Outperform | GBX 5,900 | |
| 1/9/2017 | Bryan, Garnier & Co | Reiterated Rating | Buy | GBX 6,800 | |
| 11/7/2016 | AlphaValue | Reiterated Rating | Buy | GBX 6,714 | |
| 11/3/2016 | Bank of America Corporation | Reiterated Rating | Buy | GBX 6,970 | |
| 6/3/2016 | Morgan Stanley | Reiterated Rating | Overweight | GBX 5,600 | |
| 3/15/2016 | Sanford C. Bernstein | Reiterated Rating | Outperform | GBX 5,000 | |
| 1/12/2016 | S&P Equity Research | Reiterated Rating | Buy | | |
| 12/3/2015 | Investec | Downgrade | Sell | | |
| 11/3/2015 | Kepler Capital Markets | Lower Price Target | Buy | GBX 6,000 -> GBX 5,900 | |
(Data available from 9/25/2015 forward)
Earnings History for Shire PLC (LON:SHP)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for Shire PLC (LON:SHP)Current Year EPS Consensus Estimate: $5.00 EPS
Dividend History by Quarter for Shire PLC (LON SHP)| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 8/3/2017 | | GBX 3.85 | 0.1% | 9/7/2017 | 9/7/2017 | 10/20/2017 |
| 2/16/2017 | | GBX 20.64 | 0.43% | 3/9/2017 | 3/9/2017 | 4/25/2017 |
| 8/2/2016 | | GBX 3.51 | 0.07% | 9/8/2016 | 9/8/2016 | 10/7/2016 |
| 2/11/2016 | | GBX 15.32 | 0.44% | 3/10/2016 | 3/10/2016 | 4/12/2016 |
| 7/23/2015 | | GBX 2.69 | 0.05% | 9/3/2015 | 9/3/2015 | 10/2/2015 |
| 7/18/2014 | | GBX 2.24 | 0.04% | 9/3/2014 | 9/3/2014 | 10/3/2014 |
| 2/13/2014 | | GBX 10.21 | 0.31% | 3/5/2014 | 3/5/2014 | 4/8/2014 |
(Data available from 1/1/2013 forward)
Insider Trading and Institutional Ownership History for Shire PLC (LON:SHP)Insider Trades by Quarter for Shire PLC (LON:SHP)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 8/22/2017 | Flemming Ornskov | Insider | Buy | 8,400 | GBX 3,665 | £307,860 | |
| 6/30/2017 | Dominic Blakemore | Insider | Buy | 152 | GBX 4,255 | £6,467.60 | |
| 3/31/2017 | William Burns | Insider | Buy | 136 | GBX 4,742 | £6,449.12 | |
| 12/16/2016 | Olivier Bohuon | Insider | Buy | 141 | GBX 4,528 | £6,384.48 | |
| 9/30/2016 | Dominic Blakemore | Insider | Buy | 133 | GBX 5,010 | £6,663.30 | |
| 6/30/2016 | Bohuon,Olivier | Insider | Buy | 134 | GBX 4,463 | £5,980.42 | |
| 3/31/2016 | Bohuon,Olivier | Insider | Buy | 133 | GBX 3,908 | £5,197.64 | |
| 2/15/2016 | Bohuon,Olivier | Insider | Buy | 1,000 | GBX 3,552 | £35,520 | |
| 2/12/2016 | Burns,William | Insider | Buy | 1,250 | GBX 3,563 | £44,537.50 | |
| 12/18/2015 | Burns,William | Insider | Buy | 156 | GBX 4,457 | £6,952.92 | |
| 9/30/2015 | Blakemore ,Dominic | Insider | Buy | 129 | GBX 4,498 | £5,802.42 | |
| 6/30/2015 | Kappler,David J | Insider | Buy | 126 | GBX 51.05 | GBX 6,432.30 | |
| 3/31/2015 | Susan Kilsby | Insider | Buy | 375 | GBX 5,327 | £19,976.25 | |
| 12/19/2014 | Steven Gillis | Insider | Buy | 228 | GBX 4,654 | £10,611.12 | |
| 10/30/2014 | Steven Gillis | Insider | Buy | 381 | GBX 4,098 | £15,613.38 | |
(Data available from 1/1/2013 forward)
Headline Trends for Shire PLC (LON:SHP)
Latest Headlines for Shire PLC (LON:SHP)
| Source: |
|
| Date | Headline |
|---|
 | Shore Capital Reiterates "Buy" Rating for Shire PLC (SHP)
www.americanbankingnews.com - September 24 at 6:30 AM |
 | Is Shire plc (SHPG) a Suitable Value Stock?
finance.yahoo.com - September 23 at 6:34 AM |
| J P Morgan Chase & Co Cuts Shire PLC (SHP) Price Target to GBX 5,300
www.americanbankingnews.com - September 17 at 6:28 PM |
| Shire PLC (SHP) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - September 13 at 10:36 AM |
| Shire Plc – Value Analysis (LONDON:SHP) : September 13, 2017
finance.yahoo.com - September 13 at 9:08 AM |
 | Shire's Investigational Subcutaneous C1 esterase inhibitor (C1 INH [Human]) Liquid for Injection (S
www.nasdaq.com - September 12 at 9:46 AM |
 | TOP NEWS: Shire Gets Fast-Track Designation For SHP607 In Lung Disease
www.morningstar.co.uk - September 12 at 9:46 AM |
 | Shire's SHP607 Fast Track'd in U.S. for preventing chronic lung disease in extremely premature infants
seekingalpha.com - September 12 at 9:46 AM |
 | Shire Plc Announces Fast Track Designation For SHP607 - Quick Facts
www.rttnews.com - September 12 at 9:46 AM |
| Shire Plc breached its 50 day moving average in a Bullish Manner : SHP-GB : September 11, 2017
finance.yahoo.com - September 11 at 6:49 AM |
| Shire PLC Plans Dividend of GBX 3.85 (SHP)
www.americanbankingnews.com - September 2 at 10:18 AM |
 | Shire plc Director and Senior Management Changes - GlobeNewswire - GlobeNewswire (press release)
globenewswire.com - August 23 at 11:35 AM |
| Flemming Ornskov Purchases 8,400 Shares of Shire PLC (SHP) Stock
www.americanbankingnews.com - August 22 at 1:14 PM |
 | Shire's finance head Jeff Poulton to step down
www.marketwatch.com - August 22 at 6:40 AM |
| Shire PLC (SHP) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - August 19 at 10:50 AM |
| Denmark's ISS hit by headwind in Sweden and China, shares down
finance.yahoo.com - August 17 at 7:33 AM |
| Shire Announces Submission Of MAA For Lifitegrast - Quick Facts
www.nasdaq.com - August 16 at 7:29 AM |
| Shire PLC (LON:SHP) Price Target Lowered to GBX 5,250 at Jefferies Group LLC
www.americanbankingnews.com - August 7 at 6:34 AM |
| Edited Transcript of SHP.L earnings conference call or presentation 3-Aug-17 1:00pm GMT
finance.yahoo.com - August 5 at 7:00 AM |
 | BHP Billiton plc and Shire plc could be the FTSE 100’s best bargains
www.fool.co.uk - July 30 at 6:10 AM |
| Shire PLC (SHP) Stock Rating Reaffirmed by J P Morgan Chase & Co
www.americanbankingnews.com - July 23 at 10:04 AM |
| [$$] Shire boss says share price at odds with drugs pipeline
finance.yahoo.com - July 16 at 3:55 PM |
| Shire PLC (LON:SHP) Stock Rating Upgraded by HSBC Holdings plc
www.americanbankingnews.com - July 9 at 2:16 PM |
| Royal Bank Of Canada Reiterates Outperform Rating for Shire PLC (SHP)
www.americanbankingnews.com - July 8 at 8:32 AM |
| Shire Completes NDA Filing for Hemophilia Drug with FDA
finance.yahoo.com - July 7 at 11:14 AM |
| British ministers call for post-Brexit drug deal with EU
finance.yahoo.com - July 4 at 7:20 AM |
| Shire PLC (LON:SHP) Price Target Cut to GBX 6,400 by Analysts at Goldman Sachs Group, Inc. (The)
www.americanbankingnews.com - July 3 at 10:46 PM |
| Shire PLC's (LON:SHP) "Buy" Rating Reiterated at Deutsche Bank AG
www.americanbankingnews.com - July 3 at 5:10 PM |
| Barclays PLC Reiterates Overweight Rating for Shire PLC (LON:SHP)
www.americanbankingnews.com - July 3 at 1:33 PM |
| Insider Buying: Shire PLC (LON:SHP) Insider Acquires 152 Shares of Stock
www.americanbankingnews.com - July 3 at 1:20 PM |
| Shire PLC's (SHP) Hold Rating Reiterated at Liberum Capital
www.americanbankingnews.com - July 2 at 10:34 PM |
| Shire PLC (SHP) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - June 30 at 11:18 AM |
| Shire PLC (SHP) Given Buy Rating at Citigroup Inc.
www.americanbankingnews.com - June 25 at 10:02 AM |
| Shire Says EMA Validates Veyvondi MAA For Treatment Of Von Willebrand Disease
www.nasdaq.com - June 22 at 1:31 PM |
| Shire (SHPG) Receives MAA Validation for Veyvondi by EMA
finance.yahoo.com - June 22 at 1:31 PM |
| Shire : FDA Approves Mydayis, New Once-Daily Option For ADHD Symptom Control
www.rttnews.com - June 21 at 5:20 AM |
| Shire plc: U.S. FDA Approves Mydayis (Mixed Salts of a Single-Entity Amphetamine Product) - A New Once-Daily Option for ADHD Symptom Control in Patients 13 Years and Older
finance.yahoo.com - June 21 at 5:20 AM |
| Shire PLC's (SHP) Overweight Rating Reaffirmed at J P Morgan Chase & Co
www.americanbankingnews.com - June 19 at 10:08 PM |
| Shire PLC (SHP) Given New GBX 6,000 Price Target at Deutsche Bank AG
www.americanbankingnews.com - June 18 at 10:20 PM |
| Shire PLC (SHP) Given Hold Rating at Liberum Capital
www.americanbankingnews.com - June 18 at 10:46 AM |
| Shire PLC (SHP) Given "Overweight" Rating at Barclays PLC
www.americanbankingnews.com - June 11 at 9:38 AM |
| Jefferies Group LLC Trims Shire PLC (SHP) Target Price to GBX 5,600
www.americanbankingnews.com - June 11 at 12:26 AM |
| Shire PLC (SHP) PT Lowered to GBX 6,000 at Berenberg Bank
www.americanbankingnews.com - June 8 at 6:36 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Shire plc - SHPG
finance.yahoo.com - June 7 at 7:40 PM |
 | Brexit Winners: Why JPMorgan Is Buying UK Stocks
www.investopedia.com - June 3 at 12:20 AM |
| Shire PLC (SHP) Lowered to "Hold" at Liberum Capital
www.americanbankingnews.com - June 1 at 1:40 PM |
| Shire PLC (SHP) Given "Overweight" Rating at JPMorgan Chase & Co.
www.americanbankingnews.com - May 28 at 3:56 PM |
| Deutsche Bank AG Reiterates Buy Rating for Shire PLC (SHP)
www.americanbankingnews.com - May 28 at 3:56 PM |
| Shire PLC's (SHP) Overweight Rating Reiterated at Barclays PLC
www.americanbankingnews.com - May 28 at 2:38 PM |
| Shire PLC (SHP) Lowered to Reduce at HSBC Holdings plc
www.americanbankingnews.com - May 28 at 2:02 PM |
Shire PLC (SHP) Chart for Monday, September, 25, 2017
